Expanding Kelch13 artemisinin resistance markers are associated with higher malaria incidence in Uganda

Abstract

Artemisinin partial resistance (ART-R)-associated Plasmodium falciparum Kelch13 mutations are expanding across Africa. However, their population-level consequences remain poorly understood, particularly in settings of moderate-to-high malaria transmission. We investigated associations between Kelch13 and partner drug mutation prevalence and monthly confirmed malaria incidence across 16 Ugandan districts from 2017 to 2022, using integrated molecular, epidemiological, climatic, malaria-control, and antimalarial resistance data and negative binomial regression. Combined prevalence of WHO-validated and candidate Kelch13 mutations increased over the study period. Each 10-percentage-point increase in Kelch13 prevalence was associated with a 13.1% higher incidence after multivariable adjustment (aIRR 1.131, 95% CI 1.090-1.174). Furthermore, each 10% increase in pfcrt K76T was associated with a 24% increase in malaria transmission. As expected, ITN distribution [≥]80%, IRS coverage [≥]90%, and higher altitude were associated with lower incidence, whereas temperatures of 25-30{degrees}C, relative humidity of 60-80%, and higher precipitation were associated with higher incidence. The persistence of the Kelch13 and pfcrt K76T association after adjustment suggests that expanding ART-R-associated parasite populations are independently associated with malaria incidence. The relationship may be bidirectional. These findings support interpreting ART-R within its ecological and intervention context and integrating molecular, epidemiological, and malaria-control surveillance to safeguard antimalarial efficacy.

Association between Plasmodium falciparum Kelch13 mutations and malaria parasite clearance half-life after artemisinin-based therapy: an updated WWARN systematic review and individual patient data meta-analysis
S. van Wyk, WWARN KELCH13 STUDY GROUP, P. J. Rosenthal +4
medRxiv8 Sep 2026PreprintCC BY-NDFull text1 citedInfectious diseasemedRxiv
Design, synthesis and biological evaluation of novel artemisinin derivatives as potent P-glycoprotein modulators for overcoming multidrug resistance.
Jerónimo Laiolo, Artemis Tsirogianni, Cecilia L Barbieri +8
RSC advances26 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
First Detection of WHO-validated artemisinin resistance Plasmodium falciparum K13 C469Y mutation in patient from Senegal.
A. Gaye, B. Ngom, D. Sow +25
medRxiv11 Sep 2026PreprintCC BYFull text1 citedInfectious diseasemedRxiv
Spatial surveillance of Plasmodium falciparum Kelch 13 mutations reveals High-Frequency A675V and the First Molecular Evidence of Suspected Partial Artemisinin Resistance in Baringo in Kenya.
Hoseah M Akala, Benjamin H Opot, Dennis W Juma +27
Malaria journal5 Oct 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMCPMC
Global trends in the burden of malaria: mapping the prevalence, incidence and mortality of Plasmodium falciparum and Plasmodium vivax in the era of climate change and emerging drug resistance.
Ebrahim Abbasi
BMJ global health1 Oct 2026Peer-reviewedCC BY-NCFull text15 citedEpidemiology & public healthEurope PMCOpenAlex

Cite

BibTeX RIS

BibTeX

@misc{wyk2026expanding,
  title = {{Expanding Kelch13 artemisinin resistance markers are associated with higher malaria incidence in Uganda}},
  author = {S. van Wyk and J. Gwasupika and L. Mapahla and V. Asua and L. E. Harrison and M. R. Kamya and J. I. Nankabirwa and K. I. Barnes},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.19.26365887},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.19.26365887v1},
  note = {CC BY},
}

RIS

TY  - UNPB
TI  - Expanding Kelch13 artemisinin resistance markers are associated with higher malaria incidence in Uganda
AU  - S. van Wyk
AU  - J. Gwasupika
AU  - L. Mapahla
AU  - V. Asua
AU  - L. E. Harrison
AU  - M. R. Kamya
AU  - J. I. Nankabirwa
AU  - K. I. Barnes
PY  - 2026
DA  - 2026/10/19
PB  - medRxiv
DO  - 10.64898/2026.10.19.26365887
UR  - https://www.medrxiv.org/content/10.64898/2026.10.19.26365887v1
AB  - Artemisinin partial resistance (ART-R)-associated Plasmodium falciparum Kelch13 mutations are expanding across Africa. However, their population-level consequences remain poorly understood, particularly in settings of moderate-to-high malaria transmission. We investigated associations between Kelch13 and partner drug mutation prevalence and monthly confirmed malaria incidence across 16 Ugandan districts from 2017 to 2022, using integrated molecular, epidemiological, climatic, malaria-control, and antimalarial resistance data and negative binomial regression. Combined prevalence of WHO-validated and candidate Kelch13 mutations increased over the study period. Each 10-percentage-point increase in Kelch13 prevalence was associated with a 13.1% higher incidence after multivariable adjustment (aIRR 1.131, 95% CI 1.090-1.174). Furthermore, each 10% increase in pfcrt K76T was associated with a 24% increase in malaria transmission. As expected, ITN distribution [≥]80%, IRS coverage [≥]90%, and higher altitude were associated with lower incidence, whereas temperatures of 25-30{degrees}C, relative humidity of 60-80%, and higher precipitation were associated with higher incidence. The persistence of the Kelch13 and pfcrt K76T association after adjustment suggests that expanding ART-R-associated parasite populations are independently associated with malaria incidence. The relationship may be bidirectional. These findings support interpreting ART-R within its ecological and intervention context and integrating molecular, epidemiological, and malaria-control surveillance to safeguard antimalarial efficacy.
ER  -

Abstract

Related

Cite